This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Petersen, R Articles by Barklis, E Search for Related Content PubMed PubMed Citation Articles by Petersen, R Articles by Barklis, E

 Previous Article  |  Next Article 

Mol Cell Biol. 1991 March; 11(3): 1214-1221

A stem cell-specific silencer in the primer-binding site of a retrovirus.

Vollum Institute for Advanced Biomedical Research, Oregon Health Sciences University, Portland 97201.

ABSTRACT

Retrovirus expression in embryonal carcinoma (EC) cells is blocked at a postintegration stage of the viral life cycle, in part because of the inadequate function of the viral long terminal repeat promoter in this cell type. However, selection for retrovirus expression in EC cells has identified mutations in Moloney murine leukemia virus (M-MuLV) located in the tRNA primer-binding site (PBS) region which relieve the EC cell-specific repression. We have found that exchanging the M-MuLV proline PBS for a glutamine one in a recombinant virus permits expression in EC cells. By using the recombinant virus as a backbone, the EC cell-specific repressor-binding site (RBS) element has been mapped to M-MuLV nucleotides 147 to 174. The RBS does not require precise positioning downstream of the M-MuLV promoter and can function in either orientation and in an intron, indicating that the regulatory effect is probably at the DNA, rather than RNA, level. We also show that the RBS element can repress heterologous promoters from an upstream position. Our results indicate that the RBS acts as a silencer that its inhibitory effect is mediated by a trans-acting factor, and that the mechanism of action is probably at the level of transcription. Through in vitro binding assays we have identified a binding factor which specifically recognizes the wild-type RBS sequence (binding factor A). The binding characteristics of factor A suggest that it is a stem cell repressor which acts at the M-MuLV RBS. Our DNA-binding assays also have identified a unique binding factor (binding factor Hp) which specifically recognizes a hemimethylated form of the wild-type RBS. This factor may play a role in methylation mediated control of retrovirus expression in EC cells.

This article has been cited by other articles:

• Wolf, D., Hug, K., Goff, S. P. (2008). TRIM28 mediates primer binding site-targeted silencing of Lys1,2 tRNA-utilizing retroviruses in embryonic cells. Proc. Natl. Acad. Sci. USA 105: 12521-12526 [Abstract] [Full Text]  
• Wolf, D., Cammas, F., Losson, R., Goff, S. P. (2008). Primer Binding Site-Dependent Restriction of Murine Leukemia Virus Requires HP1 Binding by TRIM28. J. Virol. 82: 4675-4679 [Abstract] [Full Text]  
• Haas, D. L., Lutzko, C., Logan, A. C., Cho, G. J., Skelton, D., Jin Yu, X., Pepper, K. A., Kohn, D. B. (2003). The Moloney Murine Leukemia Virus Repressor Binding Site Represses Expression in Murine and Human Hematopoietic Stem Cells. J. Virol. 77: 9439-9450 [Abstract] [Full Text]  
• Bartosch, B., Weiss, R. A., Takeuchi, Y. (2002). PCR-based cloning and immunocytological titration of infectious porcine endogenous retrovirus subgroup A and B. J. Gen. Virol. 83: 2231-2240 [Abstract] [Full Text]  
• Levine, A. M., Scadden, D. T., Zaia, J. A., Krishnan, A. (2001). Hematologic Aspects of HIV/AIDS. ASH Education Book 2001: 463-478 [Abstract] [Full Text]  
• Modin, C., Pedersen, F. S., Duch, M. (2000). Lack of Shielding of Primer Binding Site Silencer-Mediated Repression of an Internal Promoter in a Retrovirus Vector by the Putative Insulators scs, BEAD-1, and HS4. J. Virol. 74: 11697-11707 [Abstract] [Full Text]  
• Cherry, S. R., Biniszkiewicz, D., van Parijs, L., Baltimore, D., Jaenisch, R. (2000). Retroviral Expression in Embryonic Stem Cells and Hematopoietic Stem Cells. Mol. Cell. Biol. 20: 7419-7426 [Abstract] [Full Text]  
• Williams, D. A., Nienhuis, A. W., Hawley, R. G., Smith, F. O. (2000). Gene Therapy 2000. ASH Education Book 2000: 376-393 [Abstract] [Full Text]  
• Osborne, C. S., Pasceri, P., Singal, R., Sukonnik, T., Ginder, G. D., Ellis, J. (1999). Amelioration of Retroviral Vector Silencing in Locus Control Region beta -Globin-Transgenic Mice and Transduced F9 Embryonic Cells. J. Virol. 73: 5490-5496 [Abstract] [Full Text]  
• Robbins, P. B., Skelton, D. C., Yu, X.-J., Halene, S., Leonard, E. H., Kohn, D. B. (1998). Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 95: 10182-10187 [Abstract] [Full Text]  
• Laker, C., Meyer, J., Schopen, A., Friel, J., Heberlein, C., Ostertag, W., Stocking, C. (1998). Host cis-Mediated Extinction of a Retrovirus Permissive for Expression in Embryonal Stem Cells during Differentiation. J. Virol. 72: 339-348 [Abstract] [Full Text]  
• von Melchner, H, DeGregori, J V, Rayburn, H, Reddy, S, Friedel, C, Ruley, H E (1992). Selective disruption of genes expressed in totipotent embryonal stem cells.. Genes Dev. 6: 919-927 [Abstract]  
• Licht, T., Haskins, M., Henthorn, P., Kleiman, S. E., Bodine, D. M., Whitwam, T., Puck, J. M., Gottesman, M. M., Melniczek, J. R. (2002). Drug selection with paclitaxel restores expression of linked IL-2 receptor gamma -chain and multidrug resistance (MDR1) transgenes in canine bone marrow. Proc. Natl. Acad. Sci. USA 99: 3123-3128 [Abstract] [Full Text]